相关实验视频
Updated: Jun 11, 2025

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
148
在重症患者中推导和验证综合性败血症引起的急性呼吸衰竭表型:一项回顾性研究
Tilendra Choudhary1, Pulakesh Upadhyaya2, Carolyn M Davis3,4
1Department of Surgery, Duke University School of Medicine, Durham, NC, 27707, USA. tilendra.choudhary@duke.edu.
Critical care (London, England)
|October 1, 2024
概括
研究人员在重症患者中确定了四种不同表型的败血症引起的急性呼吸衰竭 (ARF). 这些败血症-ARF表型显示出不同的临床过程和死亡率,为量身定制的治疗策略提供信息.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 医疗保健中的机器学习
背景情况:
- 在机械通风患者中,败血症引起的急性呼吸衰竭 (ARF) 是高度异质的.
- 识别不同的患者表型对于理解败血症异质性和多器官动态至关重要.
- 这项研究旨在推导和验证败血症诱导的ARF的新型表型.
研究的目的:
- 通过观察性临床数据,利用败血症诱导的ARF的新型表型.
- 调查这些衍生的表型在不同重症监护病房和医院环境中的概括性.
- 探索已识别的表型之间的临床过程,结果和治疗效果的潜在差异.
主要方法:
- 一项涉及ICU患者的多中心回顾性研究,这些患者需要因败血症而进行机械通风.
- 使用可解释的机器学习集群模型在输管前的24小时临床数据上.
- 现象类型在一个中心获得,并在两个学术医院的多个ICU和外科ICU中验证.
主要成果:
- 确定了四种不同的ARF表型:严重的多器官功能障碍 (MOD) 与脏/心力衰竭的可能性 (A),严重的缺血性呼吸系统衰竭 (B),轻度缺氧 (C) 和严重的MOD与肝脏/凝血病/乳酸性酸性疾病的可能性 (D).
- 在表型 (p < 0.01) 中观察到28天死亡率的显著差异,在验证队列中一致.
- 现型显示出差异性治疗效应,特别是在高阳性末尾呼气压 (PEEP) 策略方面.
结论:
- 已识别的败血症-ARF表型表现出独特的器官损伤模式和临床结果.
- 这些独特的表型可以指导未来的研究和临床试验设计,以个性化治疗败血症的策略.
- 了解这些表型可能会改善为患有败血症诱导的ARF的重症患者量身定制的干预措施.
相关概念视频
Acute Respiratory Failure-I
176
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
176
Acute Respiratory Failure-II
179
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
179
Acute Respiratory Failure-III
162
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
162
Acute Respiratory Failure-IV
129
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
129
Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124

